Hematological Oncology

Cover image for Vol. 30 Issue 3

September 2012

Volume 30, Issue 3

Pages i–i, 109–162

  1. Editorial Board Article

    1. Top of page
    2. Editorial Board Article
    3. Original Research Articles
    1. Issue Information (page i)

      Version of Record online: 13 SEP 2012 | DOI: 10.1002/hon.2027

  2. Original Research Articles

    1. Top of page
    2. Editorial Board Article
    3. Original Research Articles
    1. Immunophenotype distinction between acute promyelocytic leukaemia and CD15− CD34− HLA-DR− acute myeloid leukaemia with nucleophosmin mutations (pages 109–114)

      Angela Ferrari, Elena Bussaglia, Josep Úbeda, Luca Facchini, Anna Aventin, Jorge Sierra and Josep F. Nomdedéu

      Version of Record online: 3 AUG 2011 | DOI: 10.1002/hon.1011

    2. Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial (pages 115–122)

      Bo Yang, Xue-chun Lu, Rui-li Yu, Xiao-hua Chi, Yang Liu, Yao Wang, Han-ren Dai, Hong-li Zhu, Li-li Cai and Wei-dong Han

      Version of Record online: 23 AUG 2011 | DOI: 10.1002/hon.1012

    3. Antileukaemia effect of rapamycin alone or in combination with daunorubicin on ph+ acute lymphoblastic leukaemia cell line (pages 123–130)

      Xi Yang, Juan Lin, Yuping Gong, Hongbing Ma, Xiao Shuai, Ruiqing Zhou, Yong Guo, Qingqing Shan and Guangcui He

      Version of Record online: 4 SEP 2011 | DOI: 10.1002/hon.1013

    4. Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma (pages 131–136)

      George Tsirakis, Constantina A. Pappa, Peggy Kanellou, Maria A. Stratinaki, Athina Xekalou, Fotios E. Psarakis, George Sakellaris, Athanasios Alegakis, Efstathios N. Stathopoulos and Michael G. Alexandrakis

      Version of Record online: 14 SEP 2011 | DOI: 10.1002/hon.1014

    5. Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study Group (pages 137–142)

      Sabrina Nicolosi Guidicelli, Armando Lopez-Guillermo, Umberto Falcone, Annarita Conconi, Alexandre Christinat, Delvys Rodriguez-Abreu, Salvatore Grisanti, Chiara Lobetti-Bodoni, Jean Claude Piffaretti, Peter W. Johnson, Giorgio Mombelli, Andreas Cerny, Emili Montserrat, Franco Cavalli and Emanuele Zucca

      Version of Record online: 21 NOV 2011 | DOI: 10.1002/hon.1015

    6. Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation (pages 143–149)

      Keni Gu, Dennis D Weisenburger, Kai Fu, Wing C Chan, Timothy C Greiner, Patricia Aoun, Lynette M Smith, Martin Bast, Zhongfen Liu, R. Gregory Bociek, Philip J Bierman, James O Armitage and Julie M Vose

      Version of Record online: 18 OCT 2011 | DOI: 10.1002/hon.1017

    7. Variations in glutathione-S-transferase genes influence risk of chronic myeloid leukemia (pages 150–155)

      Nur Özten, Asuman Sunguroğlu and Maarten C. Bosland

      Version of Record online: 4 OCT 2011 | DOI: 10.1002/hon.1018

    8. Serum free light chains in myeloma patients with an intact M protein by immunofixation: potential roles for response assessment and prognosis during induction therapy with novel agents (pages 156–162)

      Sherry Mori, Brooke S Crawford, Julianna VF Roddy, Gary Phillips, Pat Elder, Craig C Hofmeister, Yvonne Efebera and Don M Benson Jr

      Version of Record online: 26 OCT 2011 | DOI: 10.1002/hon.1019